Prevention of hyperacute xenograft rejection by intravenous immunoglobulin in the pig-to-human combination.
Gautreau
C
C
Laboratoire de Recherche Chirurgicale, Faculté de Médecine Cochin-Hôpital Cochin, Paris, France.
Cardoso
J
J
Woimant
G
G
Zhao
Z
Z
Chereau
C
C
Cherruau
B
B
Vandeginste
N
N
Devillier
P
P
Houssin
D
D
D000208:Acute Disease; D000818:Animals; D001803:Blood Transfusion; D003165:Complement System Proteins / Q000276:immunology; D003602:Cytotoxicity, Immunologic; D004730:Endothelium, Vascular / Q000276:immunology; D004912:Erythrocytes / Q000276:immunology; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007165:Immunosuppression Therapy / Q000379:methods; D008214:Lymphocytes / Q000276:immunology; D013552:Swine; D014183:Transplantation, Heterologous / Q000276:immunology*
D016756:Immunoglobulins, Intravenous; D003165:Complement System Proteins